Search Results

There are 9264 results for: content related to: Safety and Efficacy of Aliskiren/Amlodipine/Hydrochlorothiazide Triple Combination in Patients With Moderate to Severe Hypertension: A 54-Week, Open-Label Study

  1. You have free access to this content
    Aliskiren in the Treatment of Hypertension and Organ Damage

    Cardiovascular Therapeutics

    Volume 29, Issue 1, February 2011, Pages: 77–87, Graziano Riccioni

    Version of Record online : 25 NOV 2010, DOI: 10.1111/j.1755-5922.2010.00230.x

  2. You have free access to this content
    Posters

    The Journal of Clinical Hypertension

    Volume 12, Issue s1, April 2010, Pages: A18–A147,

    Version of Record online : 1 APR 2010, DOI: 10.1111/j.1751-7176.2010.00282.x

  3. Blood pressure lowering efficacy of renin inhibitors for primary hypertension

    Intervention Review

    The Cochrane Library

    Vijaya M Musini, Kendra AK Lawrence, Patricia M Fortin, Ken Bassett and James M Wright

    Published Online : 5 APR 2017, DOI: 10.1002/14651858.CD007066.pub3

  4. Treatment with aliskiren/amlodipine combination in patients with moderate-to-severe hypertension: a randomised, double-blind, active comparator trial

    International Journal of Clinical Practice

    Volume 66, Issue 9, September 2012, Pages: 834–842, R. C. Braun-Dullaeus, S. B. Shustov, C. Alvarez, G. G. Rogelio, J. Zhang, S. Hristoskova and D. A. Häring

    Version of Record online : 17 AUG 2012, DOI: 10.1111/j.1742-1241.2012.02967.x

  5. Pharmacokinetics of the Oral Direct Renin Inhibitor Aliskiren in Combination With Digoxin, Atorvastatin, and Ketoconazole in Healthy Subjects: The Role of P-Glycoprotein in the Disposition of Aliskiren

    The Journal of Clinical Pharmacology

    Volume 48, Issue 11, November 2008, Pages: 1323–1338, Dr Sujata Vaidyanathan, Dr Gian Camenisch, Dr Helmut Schuetz, Ms Christine Reynolds, Dr Ching-Ming Yeh, Dr Marie-Noelle Bizot, Dr Hans Armin Dieterich, Dr Dan Howard and Dr William P. Dole

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270008323258

  6. You have free access to this content
    Antihypertensive Efficacy of the Oral Direct Renin Inhibitor Aliskiren as Add-On Therapy in Patients Not Responding to Amlodipine Monotherapy

    The Journal of Clinical Hypertension

    Volume 9, Issue 10, October 2007, Pages: 742–750, Waymon Drummond, Mark A. Munger, Mohammed Rafique, Mojdeh Maboudian, Mahmudul Khan and Deborah L. Keefe

    Version of Record online : 1 OCT 2007, DOI: 10.1111/j.1524-6175.2007.06614.x

  7. Aliskiren: An Oral Direct Renin Inhibitor for the Treatment of Hypertension

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 29, Issue 2, February 2009, Pages: 193–212, Cynthia A. Sanoski

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.29.2.193

  8. You have free access to this content
    Comparative Efficacy and Safety of Combination Aliskiren/Amlodipine and Amlodipine Monotherapy in African Americans With Stage 2 Hypertension

    The Journal of Clinical Hypertension

    Volume 13, Issue 8, August 2011, Pages: 571–581, Henry R. Black, Myron H. Weinberger, Das Purkayastha, Joleen Lee, Kanaka Sridharan, Marc Israel, Robert Hilkert and Joseph Izzo

    Version of Record online : 20 JUN 2011, DOI: 10.1111/j.1751-7176.2011.00483.x

  9. Lack of pharmacokinetic interactions of aliskiren, a novel direct renin inhibitor for the treatment of hypertension, with the antihypertensives amlodipine, valsartan, hydrochlorothiazide (HCTZ) and ramipril in healthy volunteers

    International Journal of Clinical Practice

    Volume 60, Issue 11, November 2006, Pages: 1343–1356, S. VAIDYANATHAN, J. VALENCIA, C. KEMP, C. ZHAO, C-M. YEH, M-N. BIZOT, J. DENOUEL, H. A. DIETERICH and W. P. DOLE

    Version of Record online : 11 OCT 2006, DOI: 10.1111/j.1742-1241.2006.01164.x

  10. Effects of aliskiren on QT duration and dispersion in hypertensive patients with type 2 diabetes mellitus

    Diabetes, Obesity and Metabolism

    Volume 14, Issue 4, April 2012, Pages: 341–347, R. Fogari, A. Zoppi, P. Maffioli, C. Monti, P. Lazzari, A. Mugellini and G. Derosa

    Version of Record online : 27 DEC 2011, DOI: 10.1111/j.1463-1326.2011.01535.x

  11. Aliskiren-based stepped-care treatment algorithm provides effective blood pressure control

    International Journal of Clinical Practice

    Volume 65, Issue 5, May 2011, Pages: 613–623, D. Richter, C. Mickel, S. Acharya, P. Brunel and C. Militaru

    Version of Record online : 13 APR 2011, DOI: 10.1111/j.1742-1241.2011.02673.x

  12. You have free access to this content
    Aliskiren as a novel therapeutic agent for hypertension and cardio-renal diseases

    Journal of Pharmacy and Pharmacology

    Volume 64, Issue 4, April 2012, Pages: 470–481, Azhar Rashikh, Shibli Jameel Ahmad, Krishna Kolappa Pillai and Abul Kalam Najmi

    Version of Record online : 7 DEC 2011, DOI: 10.1111/j.2042-7158.2011.01414.x

  13. You have free access to this content
    Poster Abstracts

    The Journal of Clinical Hypertension

    Volume 11, Issue s1, April 2009, Pages: A16–A168,

    Version of Record online : 13 APR 2009, DOI: 10.1111/j.1751-7176.2009.00107.x

  14. You have free access to this content
    Antihypertensive Drugs and Pharmacology

    The Journal of Clinical Hypertension

    Volume 10, Issue 5SA, May 2008, Pages: A6–A37,

    Version of Record online : 11 OCT 2011, DOI: 10.1111/j.1751-7176.2008.tb00041.x

  15. You have free access to this content
    Comparison of Aliskiren/Hydrochlorothiazide Combination Therapy and Amlodipine Monotherapy in Patients With Stage 2 Systolic Hypertension and Type 2 Diabetes Mellitus

    The Journal of Clinical Hypertension

    Volume 13, Issue 12, December 2011, Pages: 889–897, Raymond R. Townsend, 1 Alan D. Forker, 2 Vaishali Bhosekar, 3 Anthony Yadao and 4 Deborah L. Keefe 4

    Version of Record online : 11 NOV 2011, DOI: 10.1111/j.1751-7176.2011.00552.x

  16. Pharmacokinetics and Pharmacodynamics of Aliskiren/Hydrochlorothiazide Single-Pill Combination Tablets and Free Combination of Aliskiren and Hydrochlorothiazide

    The Journal of Clinical Pharmacology

    Volume 52, Issue 5, May 2012, Pages: 645–655, Dr Jing-He Yan, Dr Venkateswar Jarugula, Dr Ron Sabo, Dr Cheraz Cherif Papst, Dr Jack Zhang and Dr William P. Dole

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011405499

  17. Influence of Body Weight and Gender on the Pharmacokinetics, Pharmacodynamics, and Antihypertensive Efficacy of Aliskiren

    The Journal of Clinical Pharmacology

    Volume 50, Issue 12, December 2010, Pages: 1358–1366, Dr Venkateswar Jarugula, Dr Ching-Ming Yeh, Dr Dan Howard, Dr Christopher Bush, Dr Deborah L. Keefe and Dr William P. Dole

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270009359525

  18. You have free access to this content
    Peripheral and Central Blood Pressure Responses of Combination Aliskiren/Hydrochlorothiazide and Amlodipine Monotherapy in African American Patients With Stage 2 Hypertension: The ATLAAST Trial

    The Journal of Clinical Hypertension

    Volume 13, Issue 5, May 2011, Pages: 366–375, Keith C. Ferdinand, James Pool, Richard Weitzman, Das Purkayastha and Raymond Townsend

    Version of Record online : 18 JAN 2011, DOI: 10.1111/j.1751-7176.2010.00416.x

  19. Effect of Verapamil on the Pharmacokinetics of Aliskiren in Healthy Participants

    The Journal of Clinical Pharmacology

    Volume 51, Issue 2, February 2011, Pages: 218–228, Sam Rebello, Selene Leon, Sam Hariry, Marion Dahlke and Venkateswar Jarugula

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010365717

  20. Effect of Cyclosporine on the Pharmacokinetics of Aliskiren in Healthy Subjects

    The Journal of Clinical Pharmacology

    Volume 51, Issue 11, November 2011, Pages: 1549–1560, Dr Sam Rebello, Dr Séverine Compain, Dr Aimin Feng, Mr Sam Hariry, Dr Hans-Armin Dieterich and Dr Venkateswar Jarugula

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270010385934